SweetValueLab
Write for us

LyondellBasell Industries N.V. — Wall Street Analyst Estimates & Price Targets

LYB
NYSEBasic MaterialsChemicals - SpecialtyCIK 0001489393lyondellbasell.comAbout LYB
Last close · Oct 16, 202664.01+1.34 (+2.14%)
Market cap$20.7B

6 firms' latest targets, last 90 days: median $67.00 ($62.00–$72.00), 5% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$40.0$60.0$80.0$100NovJan 2026MarMayJulSep2025-10-17 · Goldman Sachs: $51.02025-11-03 · Mizuho Securities: $52.02025-11-04 · UBS: $41.02025-12-03 · Fermium Research: $50.02025-12-11 · Mizuho Securities: $49.02025-12-15 · BMO Capital: $36.02025-12-19 · Wells Fargo: $45.02025-12-23 · UBS: $38.02026-01-07 · Vertical Research: $48.02026-01-16 · RBC Capital: $49.02026-02-02 · Mizuho Securities: $53.02026-02-02 · Wells Fargo: $48.02026-02-03 · RBC Capital: $51.02026-02-23 · BMO Capital: $38.02026-03-04 · RBC Capital: $94.02026-03-04 · KeyBanc: $73.02026-03-09 · Fermium Research: $74.02026-03-09 · Vertical Research: $75.02026-03-09 · RBC Capital: $82.02026-03-12 · Wells Fargo: $76.02026-03-26 · UBS: $79.02026-04-09 · Alembic Global: $1002026-04-10 · RBC Capital: $91.02026-04-21 · Morgan Stanley: $77.02026-05-05 · BMO Capital: $88.02026-05-05 · UBS: $82.02026-05-05 · Wells Fargo: $80.02026-05-28 · Wells Fargo: $98.02026-06-05 · UBS: $73.02026-07-01 · Mizuho Securities: $62.02026-07-02 · Alembic Global: $83.02026-07-03 · Wells Fargo: $70.02026-07-06 · BMO Capital: $64.02026-07-16 · Goldman Sachs: $62.02026-07-20 · Morgan Stanley: $72.02026-08-03 · BMO Capital: $68.02026-08-03 · Mizuho Securities: $66.02026-08-03 · RBC Capital: $80.02026-08-04 · UBS: $64.02026-08-05 · RBC Capital: $72.02026-09-25 · UBS: $62.02026-10-12 · Barclays: $66.02026-10-13 · RBC Capital: $68.0
$40.0$60.0$80.0$100NovFebMayAug

Each firm's latest target

last 90 days · 6 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-13RBC Capital$68.00$72.00▼ 6%+14%+6%
2026-10-12Barclays$66.00——+11%+3%
2026-09-25UBS$62.00$64.00▼ 3%+4%-3%
2026-08-03BMO Capital$68.00$64.00▲ 6%+10%+6%
2026-08-03Mizuho Securities$66.00$62.00▲ 6%+6%+3%
2026-07-20Morgan Stanley$72.00$77.00▼ 6%+21%+12%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2021reported$45.1B+67%$16.75+295%est. $45.3B+0%est. $18.466
2022reported$49.4B+10%$11.81-29%est. $51.0B-3%est. $12.395
2023reported$41.1B-17%$6.46-45%est. $41.2B+0%est. $8.7412
2024reported$40.3B-2%$4.15-36%est. $40.1B+0%est. $6.4411
2025reported$30.2B-25%-$2.34-156%est. $30.0B+1%est. $2.1310
2026$33.2B+10%$9.14+330%$30.6B–$36.7B$8.67–$9.6012
2027$31.6B-5%$6.11-33%$27.5B–$34.4B$4.81–$8.1412
2028$32.6B+3%$6.48+6%$29.5B–$36.8B$5.46–$7.0113
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.